Alimera Sciences, Inc. (ALIM)の価格はいくらですか

Alimera Sciences, Inc. (ALIM)の価格は$5.54です

Alimera Sciences, Inc. (ALIM)の時価総額は何ですか

Alimera Sciences, Inc. (ALIM)の時価総額は$38.76Mです

Alimera Sciences, Inc.（ALIM）株式分割

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

年	株式分割	分割比率	累積分割比率
2019-11-15	1:15	x0.066666666666667	x0.066666666666667

年

株式分割

分割比率

累積分割比率

2019-11-15

1:15

x0.066666666666667

企業	株式分割の回数	累積分割比率	国
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

企業

株式分割の回数

累積分割比率

国